EMA says J&J Covid-19 vaccine benefits outweigh the risks despite finding possible link to rare blood clots

The European

The European Medicines Agency (EMA) has given its backing to the Johnson & Johnson Covid-19 vaccine, saying the overall benefit-risk remains positive, despite warning about the very rare possible side effect of blood clots.

The EU drug regulator’s safety committee conducted an investigation into the side effects of the Johnson & Johnson vaccine after the US Food and Drug Administration (FDA) suspended its use in America earlier this month “out of an abundance of caution.”

Continue reading https://on.rt.com/b6hc